翰思艾泰生物医药科技（武汉）股份有限公司（股票名称“翰思艾泰-B”，股票代码03378）于2026年4月15日发布公告称，公司当日于香港联交所场内回购股份21,500股，占回购前已发行股本约0.016%。回购价格介乎每股28.2港元至29.8港元，总金额约61.99万港元。
公告显示，完成回购后，公司已发行股本（不包括库藏股份）为136,018,030股，库藏股份数为200,800股。公司回购授权于2026年2月12日通过，可回购股份总数为13,621,883股。
公司同时声明，本次股份回购已遵守香港联交所相关上市规则与适用法律规定。该公告由董事长兼执行董事张发明签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.